Fuso Pharmaceutical Industries, Ltd.

4538・Prime Market・Pharmaceuticals

Official website

Fuso Pharmaceutical Industries, Ltd.

4538・Prime Market・Pharmaceuticals

Official website

Fuso Pharmaceutical Industries, Ltd.4538

Reference Indicators

Market Cap

207¥100M

P/E (Forecast)

—

P/B

0.5x

Dividend Yield (Forecast)

4.11%

ROE

5.9%

EV/EBITDA

8.4x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	49,632	51,015	55,407	60,563	62,307
Cost of Sales	36,235	37,275	41,568	44,030	46,312
Gross Profit	13,397	13,740	13,838	16,532	15,995
SG&A Expenses	11,473	11,533	11,874	12,401	13,355
Operating Income	1,924	2,206	1,964	4,131	2,639
Non-operating Income	376	390	232	235	273
Non-operating Expenses	304	380	328	586	563
Ordinary Income	1,996	2,215	1,868	3,780	2,349
Extraordinary Income	—	—	39	—	118
Extraordinary Losses	85	10	140	8,751	28
Pre-tax Income	1,911	2,205	1,767	-4,970	2,438
Income Taxes	427	599	389	-1,682	426
Net Income	1,483	1,605	1,377	-3,288	2,011
EBITDA	4,483	4,692	4,227	6,485	5,257
Gross Margin	27.0%	26.9%	25.0%	27.3%	25.7%
Operating Margin	3.9%	4.3%	3.5%	6.8%	4.2%
ROA	2.1%	2.2%	1.8%	-4.0%	2.2%
ROE	4.3%	4.6%	3.8%	-9.4%	5.9%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	0	0	0.0%
不動産事業	0	0	0.0%